{"id":"https://openalex.org/A5128762165","orcid":null,"observed_orcids":[],"display_name":"Matt Vassar","raw_author_names":["Matt Vassar"],"full_name":"Matt Vassar","works_count":5,"cited_by_count":0,"summary_stats":{"2yr_mean_citedness":0.0,"h_index":0,"i10_index":0},"ids":{"openalex":"https://openalex.org/A5128762165","orcid":null,"observed_orcids":[]},"affiliations":[{"institution":{"id":"https://openalex.org/I74022624","ror":"https://ror.org/02mfxdp77","display_name":"Oklahoma State University Center for Health Sciences","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I74022624"]},"years":[2026]}],"last_known_institutions":[{"id":"https://openalex.org/I74022624","ror":"https://ror.org/02mfxdp77","display_name":"Oklahoma State University Center for Health Sciences","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I74022624"]}],"topics":[{"id":"https://openalex.org/T10206","display_name":"Meta-analysis and systematic reviews","count":4,"subfield":{"id":"https://openalex.org/subfields/1804","display_name":"Statistics, Probability and Uncertainty"},"field":{"id":"https://openalex.org/fields/18","display_name":"Decision Sciences"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11649","display_name":"Pharmaceutical industry and healthcare","count":3,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","count":2,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","count":2,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10279","display_name":"Urinary Bladder and Prostate Research","count":1,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"topic_share":[{"id":"https://openalex.org/T11649","display_name":"Pharmaceutical industry and healthcare","value":2.23e-05,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10206","display_name":"Meta-analysis and systematic reviews","value":1.93e-05,"subfield":{"id":"https://openalex.org/subfields/1804","display_name":"Statistics, Probability and Uncertainty"},"field":{"id":"https://openalex.org/fields/18","display_name":"Decision Sciences"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","value":9.3e-06,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","value":7.6e-06,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10984","display_name":"Sinusitis and nasal conditions","value":5.9e-06,"subfield":{"id":"https://openalex.org/subfields/2733","display_name":"Otorhinolaryngology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"x_concepts":[{"id":"71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","score":0.9380000233650208},{"id":"535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","score":0.689300000667572},{"id":"177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","score":0.5375999808311462},{"id":"2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","score":0.4661000072956085},{"id":"12174686","wikidata":"https://www.wikidata.org/wiki/Q1058438","display_name":"Risk assessment","score":0.3628000020980835}],"counts_by_year":[{"year":2026,"works_count":5,"oa_works_count":5,"cited_by_count":0}],"display_name_alternatives":["Matt Vassar"],"block_key":"m vassar","works_api_url":"https://api.openalex.org/works?filter=author.id:A5128762165","updated_date":"2026-10-15T12:44:11","created_date":"2026-02-11T00:00:00"}